Furthermore, administration of a small molecule inhibitor of STAT3 in rodent models of CKD increases muscle size and grip strength [74,478], suggesting that blocking pro-inflammatory signaling pathways might be beneficial. Here, STAT3 is linked to chronic kidney disease.